Oslobađanje celekoksiba iz mukoadhezivnih diskova s polimerima poliaspartamidnog tipa by Ballian Krznar, Davorka et al.
Mucoadhesive drug delivery systems are very beneficial, since they can prolong the
residence time of the drug at the site of absorption and increase drug bioavailability.
Hydrogels, hydrophilic polymer networks, are often used as mucoadhesive drug deli-
very systems for their biocompatibility and similarity to a natural tissue (1) as well as for
their ability to control drug release and to protect it from a hostile environment. The mu-
coadhesive polymers forming hydrogels are hydrophilic and swellable, containing nu-
merous hydrogen bond forming groups, like hydroxyl, carboxyl or amine, which favor
adhesion. When used in a dry form, they attract water from the mucosal surface and
swell, leading to polymer/mucus interaction through hydrogen bonding, electrostatic,
hydrophobic or van der Waals interactions.
Thiolated polymers (thiomers), are relatively new mucoadhesive excipients, which
are capable of forming covalent bonds with the mucus layer covering mucosal tissues
(2). Various thiomers, thiolated derivatives of polycarbophil, carboxymethyl cellulose,
alginate and chitosan have been synthesized and evaluated in mucoadhesive drug de-
livery systems (see, for example, refs. 3–7). Several thiomers of polyaspartamide types
were described in our previous papers. Chemical modification of poly,-(N-2-hydro-
xyethyl-DL-aspartamide) (PHEA) with thiol bearing molecules led to thiomers of im-
proved mucoadhesive properties. PHEA was first thiolated with thioglycolic acid and
the resulting conjugate was successfully used in the preparation of microspheres with
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loratadine (8, 9), while two similar copolymers, poly,-(N-2-aminoethyl-DL-asparta-
mide)-poly,-(N-2-hydroxyethyl-DL-aspartamide)-poly,-(N-2-thioethyl-DL-aspar
tamide) copolymer (PAHTA) and poly,-(N-2-aminoethyl-DL-aspartamide)-poly,-(N-
-2-hydroxyethyl-DL-aspartamide)-poly,-(N-3-mercapto-1-methoxycarbonyl-propyl-
D,L-aspartamide) copolymer (PAHMA) were prepared and used in the preparation of
diclofenac and fenoprofen polymer-drug conjugates (10). Finally, poly,-(N-2-hydro-
xyethyl-DL-aspartamide)-poly,-(N-2-thioethyl-DL-aspartamide) copolymer (PHTA)
was synthesized, characterized and screened as a protective polymer in quantum dots
induced cell toxicity (11, 12).
In this paper, drug/polymer disks with PHEA, PHTA, Carbopol 934P (Cp 934P)
and hydroxypropylmethyl cellulose (HPMC) are described. The effects of various ratios
of these polymers on the rate of drug release were studied as well.
Celecoxib, a selective cyclooxygenase-2 (COX 2) inhibitor was used as a model drug.
According to biopharmaceutical classification systems, celecoxib is classified as a low sol-
ubility and high permeability drug (13). By enhancing its dissolution rate, a faster onset of
action and improved oral bioavailability could be achieved.
EXPERIMENTAL
Material and methods
IR and UV spectra were recorded on GX FT-IR (Perkin Elmer, UK) and Hewlett
Packard 8452A (Hewlett Packard, Germany) spectrometers, respectively. The average
molecular mass was determined by size exclusion chromatography (SEC) with UV de-
tector (Series II, Hewlet Packard, USA). Dialysis was done with cellulose dialysis tub-
ings with a molecular mass cut-off 8,00012,000 (Sigma, USA).
Celecoxib was obtained from Cipla (India), Carbopol 934P from Noveon (Belgium)
and hydroxypropylmethyl cellulose 4000 from Dow Chemical Company (USA). Gel fil-
tration molecular mass standards were purchased from Bio Rad Laboratories CA (USA).
Cysteamine was obtained from Sigma-Aldrich (Germany), L-aspartic acid and ethanol-
amine from Kemika (Croatia). Buffer solutions pH 6.6 were prepared from 0.2 mol L–1
KH2PO4 and 0.2 mol L–1 NaOH. The amine was distilled prior to use. All solvents used
were of analytical grade and dry.
Syntheses of polymers
Poly,-(N-2-hydroxyethyl-DL-aspartamide) (PHEA, 1).  PHEA was synthesized fol-
lowing the published procedure (14, 15). PSI was prepared by thermal polycondensation
of L-aspartic acid in the presence of o-phosphoric acid (160 C, reduced pressure).
Poly,-(N-2-hydroxyethyl-DL-aspartamide)-poly,-(N-2-thioethyl-DL-aspartamide)-
copolymers (PHTA, 2a,b).  The synthetic procedure for PHTA involved partial amino-
lysis of PSI with the thiol bearing compound cysteamine, followed by aminolysis of the
remaining succinimide units with ethanolamine by the known procedure (12). Two pro-
ducts with different SH contents were prepared: 2a (91 mol g–1) and 2b (461 mol g–1).
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Molecular mass determination.  The average molecular mass of polymers 1 and 2 was
determined by size exclusion chromatography (UV detector,  = 200  10 nm). The col-
umn set was composed of a precolumn and column BioSep-SEC-S 3000, 290 Å pore size
(Phenomenex, USA). The experimental conditions were: mobile phase buffer solution
pH 6.6, flow rate 0.35 mL min–1 and injection volume 5 L. The column was calibrated
by protein molecular mass standards: thyroglobulin, 	 globulin, ovalbumin, myoglobin
and vitamin B-12. The column set, ionic strength and pH of the aqueous mobile phase
were optimized prior to the molecular mass determination.
Determination of thiol groups.  The amount of free SH groups in thiomers 2a,b was
determined by iodimetric titration (11, 12). A solution of 15 mg thiomer in 1 mL distilled
water acidified to pH 2 and 0.2 mL starch solution (0.5%, m/V) was titrated with 0.1
mmol L–1 iodine solution until permanent light-blue colour. Each determination was
performed in triplicate and the mean value was taken as final. The results were expres-
sed as micromoles per gram of thiomers.
Preparation and characterization of disks
Preparation of disks.  Celecoxib was used as a model drug in all formulations. Thio-
mers (2a and 2b) were compressed alone (F2) or with Cp 934P or HPMC (formulations
F3, F4, F6 and F8). For comparison, disks omitting thiomers were prepared with PHEA,
Cp 934P or HPMC (F1, F5, F7, F9), as well as compressed celecoxib only (F10). Polymer
or polymers mixture and celecoxib were dispersed in an appropriate amount of demi-
neralized water. The obtained suspensions were lyophilized. Disks containing 100 mg of
the drug were prepared using an IR hydraulic press (Perkin-Elmer, USA) by individual
weighing and direct compression. The compaction pressure (5 × 103 kg) and compres-
sion time (35 s) were kept constant during the preparation of all disks. The prepared
disks were 13 mm in diameter and 1 mm thick. Mass of each disk was 200  5 mg. Com-
position of the disks is shown in Table I.
In vitro dissolution profile.  Dissolution profiles were determined using USP appara-
tus II (16) at 37 °C, rotating speed of 50 rpm and phosphate buffer pH 6.6 with 0.5% so-
dium lauryl sulphate as media (500 mL). The samples were collected at predetermined
time intervals and analyzed spectrophotometrically at 255 nm. After each withdrawall
465
D. Ballian Krznar et al.: Dissolution of celecoxib from mucoadhesive disks based on polyaspartamide derivatives, Acta Pharm. 56
(2006) 463–471.
Table I. Composition of disks F1–F10
Component (mg)
Formulation
F1 F2 F3 F4 F5 F6 F7 F8 F9 F10
Celecoxib 100 100 100 100 100 100 100 100 100 100
PHEA (1) 100
  
50
    
PHTA (2a)
  
50
     
PHTA (2b)

100 50
 
75

50
 
Cp 934P
 
50 50 50 25 100
  
HPMC 4000
      
50 100

of a sample, an equal volume of fresh buffer was added to dissolution medium. Each de-
termination was performed in triplicate and the mean value was taken as final.
Statistical analysis.  Statistical significance for the comparison of release profiles
was tested by one-way ANOVA. Statistically significant differences were defined as P
values of less than 0.05. Calculations were performed with the GraphPad Prism program
(GraphPad Software, Inc., San Diego, USA; www.graphpad.com).
RESULTS AND DISCUSSION
PHEA (1) and PHTA (2) are hydrophilic polymers of polyaspartamide type bearing
hydroxy or both hydroxy and thiol groups. The starting polymer for their synthesis,
poly-DL-(2,5-dioxo-1,3-pyrrolidinediyl) (PSI), was synthesized by thermal polyconden-
sation of L-aspartic acid (14, 15). PHEA was prepared by total aminolysis of PSI with
ethanolamine, while the synthetic procedure for PHTA involved partial aminolysis of
PSI with cysteamine, followed by aminolysis of the remaining succinimide units with
ethanolamine (12). During the reaction, succinimide rings of PSI were opened and am-
ide bonds with both amines were formed. Structural formulas of polymers 1 and 2 are
presented in Scheme 1.
By varying the PSI/cysteamine molar ratio, two batches of PHTA 2a and 2b, differ-
ing in the thiol content, total sulphur and mucoadhesive properties, were prepared. The
amount of thiol groups was 91 in 2a and 461 mol per gram of polymer in 2b. Average
molecular mass of polymers 2a,b was between 63 and 65 kDa.
Our previous investigations revealed that total work of adhesion (TWA) of thiolated
polymers PHTA and PHEA conjugate with thioglycolic acid was increased 1.5 to 7.5 times,
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Scheme 1
compared to the similar nonthiolated polymer PHEA (8, 12). A clear correlation between
the amount of thiol groups and mucoadhesive properties was observed: the more thiol
groups were attached to the polymer, the higher was the TWA value. Increased bioadhe-
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Fig. 1. Dissolution profiles of pure celecoxib disk (F10) and disks made of: a) PHEA (F1), PHTA 2b
(F2), Cp 934P (F7) and HPMC (F9); b) Cp 934P/ PHTA 2b (F3), Cp 934P/PHTA 2a (F4), Cp 934P/
PHEA (F5) and HPMC/PHTA 2b (F8); c) Cp 934P/ PHTA 2b 1:1 (m/m) (F3) and Cp 934P/PHTA 2b
1:3 (m/m) (F6) (mean ± SD, n = 3).
sive properties make PHTA an interesting polymer in drug formulations. A series of disks
with celecoxib as a lipophilic model drug were prepared and characterized. Disks F1–F10
were prepared by direct compression and their composition is shown in Table I.
Dissolution data were analyzed using the Ritger and Peppas equation (17, 18) to de-
scribe the mechanism of drug release from matrices (Mt/M
) = K tn, Mt/M
 is the drug
fraction released in time t, K is a constant and the diffusional exponent, n, is an impor-
tant indicator of the mechanism of drug transport through the polymer. For disks (tab-
lets), and depending on the aspect ratio, i.e., the diameter to thickness ratio, the Fickian
diffusion mechanism is described by 0.43 < n < 0.50 and the drug release rate is time-de-
pendent. When n is between 0.5 and 1.0, the drug release rate is time-dependent, but
other factors such as polymer relaxation and swelling control the solute transport. Case-
-II type diffusion occurs when n is equal to 1.0, which indicates that the release rate is
time-independent. Super-case II transport occurs when n is greater than 1.0; in that case,
the release rate is time-dependent.
The influence of PHTA 2a and 2b alone or in combination with Cp 934P and HPMC
on dissolution properties of celecoxib from disks was studied. Regarding the dissolution
profiles (Fig. 1), there is no significant difference between the dissolution of pure cele-
coxib (F10) and dissolution of celecoxib from disks made of PHEA (F1) or PHTA 2b (F2)
alone. Up to 10% of the drug was dissolved from disks after 8 hours. The drug dissolution
from disks made of Cp 934P (F7) or HPMC (F9) alone reached 28% in 8 hours (Fig. 1a).
The dissolution profiles of celecoxib from disks F3, F4, F5 and F8 composed of poly-
mer mixtures are presented in Fig. 1b. Dissolution efficiency of each formulation achiev-
ed in 8 hours (4581%) was significantly different (p = 0.002) from the dissolution effi-
ciency of the pure drug (6%). The best dissolution was achieved from the disk composed
of PHTA 2b and Cp 934P in equal mass ratios (F3). Disks F3 and F4 differ in the content
of SH groups from PHTA, while disk F5 contains the parent polymer PHEA (without SH
groups). It can be seen from the dissolution profiles of these disks that the content of SH
groups of polymers affected the dissolution profile in such a way that the best dissolu-
tion was achieved from disk F3 with the thiomer containing the highest amount of SH
groups. The lowest dissolution efficiency (45% in 8 hours) was achieved from disk F8
made of PHTA 2b and HPMC in equal mass ratios.
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Table II. Fitting of dissolution data of celecoxib from different formulationsa
Formulation K (h–n) n R2
F3 0.0771 1.413 0.9987
F4 0.0639 1.206 0.9752
F5 0.0361 1.452 0.9928
F6 0.0448 1.108 0.9880
F7 0.0285 1.105 0.9951
F8 0.0578 1.007 0.9957
F9 0.0334 1.053 0.9881
a Ritger and Peppas equation Mt/M = K tn (17, 18)
Mt/M
  drug fraction released; t  time; K  constant; n  diffusional exponent.
The dissolution of celecoxib from the disk made of Cp 934P and PHTA 2b in 1:3
(m/m) ratio (F6) was significantly lower than that from the disks made of the same poly-
mers in 1:1 (m/m) ratio (Fig. 1c), though it was significantly higher than the dissolution
of pure drug.
The fitting of dissolution profiles according to the Ritger and Peppas equation is re-
ported in Table II. Exponents n, related to drug release kinetics, were in all cases higher
than 1, indicating that drug release was time dependent and controlled by the relaxa-
tional process due to the swelling of the polymeric network. Differences observed in n
and K values, K being a constant incorporating structural and geometric characteristics
of the device, could be explained by the difference in the swelling behaviour depending
on the polymer composition of the disks. The drug/polymer systems with the highest
values of K were F3 and F4, composed of Cp 934P and PHTA in 1:1 (m/m) ratio, which
showed the highest release rate (F3 82% and F4 71% after 8 h). The disks composed of
Cp 934P (F7) or HPMC (F9) alone gained the lowest K and lesser ability of promoting
drug release, though both polymers are very hydrophilic and swellable. Therefore, it
seems that blending of these polymers with PHTA 2b produced more swellable systems
with a promoted dissolution rate of celecoxib.
CONCLUSIONS
Hydrophilic, mucoadhesive PHTA copolymer, a polyaspartamide thiomer bearing
both hydroxy and thiol groups, was successfully used in celecoxib disk formulations
alone or in combination with Cp 934P and HPMC. Enhanced dissolution properties of
the PHTA containing disks suggest the possible use of this new polymer as an excipient
in drug delivery.
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Acronyms and codes.  COX  cyclooxygenase; Cp 934P  Carbopol 934P; HPMC  hydroxypro-
pylmethyl cellulose 4000; PAHMA  poly,-(N-2-aminoethyl-DL-aspartamide)-poly,-(N-2-
-hydroxyethyl-DL-aspartamide)-poly,-(N-3-mercapto-1-methoxycarbonyl-propyl-D,L-asparta-
mide) copolymer; PAHTA  poly,-(N-2-aminoethyl-DL-aspartamide)-poly,-(N-2-hydroxy-
ethyl-DL-aspartamide)-poly,-(N-2-thioethyl-DL-aspartamide) copolymer; PHEA  poly,-(N-
-2-hydroxyethyl-DL-aspartamide); PHTA  poly,-(N-2-hydroxyethyl-DL-aspartamide)-poly -
,-(N-2-thioethyl-DL-aspartamide) copolymer; SEC  size exclusion chromatography.
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S A @ E T A K
Osloba|anje celekoksiba iz mukoadhezivnih diskova
s polimerima poliaspartamidnog tipa
DAVORKA BALLIAN KRZNAR, JELENA FILIPOVI]-GR^I], BRANKA ZORC i MARIJANA ZOVKO
Pripravljeni su i karakterizirani mukoadhezivni diskovi s celekoksibom kao lipofil-
nom modelnom supstancijom. Kao ekscipiensi uporabljena su dva polimera poliaspart-
amidnog tipa, poli,-(N-2-hidroksietil-DL-aspartamid) (PHEA, 1) i njegov tiolirani
analog poli,-(N-2-hidroksietil-DL-aspartamid)-poli,-(N-2-tioetil-DL-aspartamid)
kopolimer (PHTA, 2a,b), te dva komercijalno dostupna polimera Carbopol 934P i hid-
roksipropilmetilceluloza 4000. Najbolji profil osloba|anja celekoksiba postignut je iz dis-
kova sastavljenih od tiomera 2b i Carbopola 934P u masenom omjeru 1:1.
Klju~ne rije~i: celekoksib, diskovi, poliaspartamid, tiomer
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